Anti-BCMA CAR T-cells in myeloma: what data do we have so far?
BCMA is an exciting therapeutic target for multiple myeloma (MM). Here, Yi Lin, MD, PhD, of the Mayo Clinic, Rochester, MN, discusses current trials of CAR T-cell products that are targeting BCMA, and...
Author: VJHemOnc
Added: 09/14/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Myeloma